St. Paul Fire and Marine Ins. Co. v. MetPath, Inc.

38 F. Supp. 2d 1087, 1998 WL 350573
CourtDistrict Court, D. Minnesota
DecidedFebruary 4, 1999
DocketCiv. 3-96-703 RHK/JMM
StatusPublished
Cited by5 cases

This text of 38 F. Supp. 2d 1087 (St. Paul Fire and Marine Ins. Co. v. MetPath, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Minnesota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
St. Paul Fire and Marine Ins. Co. v. MetPath, Inc., 38 F. Supp. 2d 1087, 1998 WL 350573 (mnd 1999).

Opinion

MEMORANDUM OPINION AND ORDER

KYLE, District Judge.

Introduction

Plaintiffs St. Paul Fire and Marine Insurance Company and St. Paul Mercury Insurance Company (collectively “St. Paul”) issued professional liability insurance to Defendant MetPath, Inc. 1 (“Met-Path”) for the policy period April 1, 1994 to April 1, 1995. During this period, Met-Path acquired Defendant Maryland Medical Laboratory, Inc. (“MML”) and added MML to its professional liability insurance policy, effective June 8, 1994. Shortly after it was added to the policy, MML informed St. Paul of three claims being brought against it and MetPath involving MML’s failure to diagnose cancer in blood tests it had performed. St. Paul filed the instant action, seeking a declaration that it was not required to defend or indemnify the Defendants for these three claims. Presently before the Court are the parties’ Cross-Motions for Summary Judgment. For the reasons set forth below, the Court will grant the Defendants’ Motion, and it will grant the Plaintiffs’ Motion in part and deny it in part.

Facts

MetPath, which is headquartered in Tet-erboro, New Jersey, is engaged in the clinical laboratory medical testing business. (Calamari Aff. ¶ 3.) MetPath operates over 1000 testing laboratories around the country. (Dierssen-Morice Aff. in Opp’n to Defs.’ Mot. for Summ.J. [hereinafter “D-M Opp’n Aff.”] Ex. 9 (Aug. 10, 1994 letter from Joseph Peiser to Daniel Fosterling).) St. Paul sold MetPath a series of “Medical Professional Liability Protection' — Claims Made” 2 insurance policies which provided coverage from April 1, 1989 to April 1, 1995. (Gasior Aff.Ex. 2 at Resp. 8 (Pis.’ Resps. to Defs.’ Reqs. for Admis.).) The final policy in this series was policy number 0566xml452 (the “Policy”), with a policy period of April 1, 1994 to April 1, 1995. {Id. at Resp. 7). Met-Path had as many as 74 separate companies insured under the Policy. (D-M Opp’n Aff.Ex. 1 (Policy Change Endorsement listing the named insureds under the Policy).)

1. The Policy

The medical professional liability protection which St. Paul provided to MetPath under the Policy included two layers of coverage. The “Medical Professional Liability Protection Claims-Made Excess of Self Insured-Retention” insuring agreement provided the first, primary layer of coverage. This provided $1,000,000 total in coverage for covered claims or suits brought during the policy period, and it was subject to a $1,000,000 each person, *1089 self-insured retention, and a total, self-insured retention of $3,000,000. 3 (Gasior Aff.Ex. 1 at SP/MET PLUF 1824 (the Policy).) The second layer of coverage was provided by the “Health Care Facility Umbrella Excess Liability Protection” coverage, which was subject to a $5,000,000 per person limit and a $15,000,000 total limit of liability. (Id. at SP/MET PLUF 1805.)

The Policy contained an exclusion for “known prior acts [hereinafter “Known Prior Acts Exclusion”]:”

Known prior acts. We won’t cover claims or suits:
—made or brought against a protected person; 4
—that a protected person know[s] about; or
—that a protected person could have foreseen or discovered in a reasonable way;
prior to the effective date of this agreement. And if this agreement is a renewal, the effective date is that of the earliest preceding agreement from which we have continuously provided the protection provided by this agreement.

(Id. at SP/MET PLUF 1830.) The Policy defined a claim as “a demand which seeks damages or your report of an injury or death that you feel will likely result in a demand which seeks damages.” (Id. at SP/MET PLUF 1825.)

St. Paul also issued MetPath a Commercial General Liability Policy (“CGL Policy”), effective for the policy period April 1, 1994 through April 1, 1995. 5 (Dierssen-Moriee Aff. in Supp. of Pis.’ Mot. for Summ.J. [hereinafter “D-M Supp.Aff.”] Ex. 17 (the CGL Policy).) The CGL Policy provided commercial general liability protection on an “occurrence” basis. It stated:

Bodily injury and property damage liability. We’ll pay amounts any protected person is legally required to pay as damages for covered bodily injury, 6 property damages, premises damage or patient’s property damage that:
—happens while this agreement is in effect; and
—is caused by an event.

(Id. at SP/MET POL 720-21.)

The CGL Policy contained the following “health care professional services” exclusion:

Health care professional services. We won’t cover injury or damage or medical expenses that result from the performance of or the failure to perform health care professional services.
Health care professional services include:
—dental, medical, mental, nursing, surgical, x-ray and other health care professional services, including food or beverages provided with those services; ....

(D-M Supp.Aff.Ex. 17 at SP/MET POL 730.)

2. MetPath Acquires MML

In 1993 and 1994, MetPath aspired to become the preeminent laboratory testing and health sciences company in the world. In order to achieve this goal, it became an “acquisitive company,” aggressively acquiring laboratories around the United *1090 States and abroad. (D-M Supp.Aff.Ex. 10 (handwritten notes dated July 27, 1994) & Ex. 11 (Aug. 10, 1994 letter from Joseph Peiser to Daniel Fosterling).) On June 8, 1994, MetPath purchased MML, a medical testing laboratory in Baltimore, Maryland. (Id. Ex. 12 (July 13, 1994 letter from Louise Lemanski to Joseph Peiser).)

On June 8, 1994, St. Paul issued to MetPath a Policy Change Endorsement that “revised” the “Named Insured/Retroactive Date Endorsement” to “include Maryland Medical Laboratory, Inc., retroactive date 11-15-87.” (D-M Opp’n Aff.Ex. 1 (Policy Change Endorsement).) The Policy Change Endorsement stated: “this endorsement summarizes the changes to your policy. All other terms of your policy not affected by these changes remain the same.” (Id.) It further stated that the “Agreement takes effect 06-08-94.” (Id.)

3. The Claims Against MML

Prior to MetPath’s purchase of MML, MML was aware that it had failed to diagnose Donna Kneeland, Charles Campbell, and Nancy Perkins with cancer. (Mum-mert Dep. 65-66, 71; Khalluf Dep. 25; Passen Dep.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
38 F. Supp. 2d 1087, 1998 WL 350573, Counsel Stack Legal Research, https://law.counselstack.com/opinion/st-paul-fire-and-marine-ins-co-v-metpath-inc-mnd-1999.